Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Plasma cell 2Myeloid 2Lymphoid 2Other hematologic neoplasm 1Classical hematology 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 14Leukemia, Myeloid, Acute 11Myelodysplastic Syndromes 9Lymphoma 8Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6Leukemia 6Hematologic Neoplasms 6Neuroblastoma 4Neoplasms 4Lymphoma, Non-Hodgkin 4Leukemia, Biphenotypic, Acute 4Leukemia, B-Cell 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Melanoma 3Leukemia, Lymphoid 3Hodgkin Disease 3Hematologic Diseases 3Sarcoma 2Rhabdoid Tumor 2Recurrence 2Preleukemia 2Precancerous Conditions 2Osteosarcoma 2Neoplasms, Germ Cell and Embryonal 2Neoplasms by Histologic Type 2Multiple Myeloma 2Lymphoproliferative Disorders 2Lymphatic Diseases 2Leukemia, Myelomonocytic, Juvenile 2Leukemia, Myeloid 2

Interventions

Dexamethasone 239Lenalidomide 145daratumumab 124Bortezomib 102pomalidomide 87Calcium Dobesilate 76carfilzomib 74Cyclophosphamide 70Specimen Handling 42isatuximab 40Biopsy 40belantamab mafodotin 37fludarabine 36Magnetic Resonance Spectroscopy 35talquetamab 29dexamethasone acetate 27dexamethasone 21-phosphate 27Melphalan 27iberdomide 26auricularum 26ixazomib 22fludarabine phosphate 22selinexor 21elotuzumab 21Whole-Body Irradiation 14X-Rays 13tocilizumab 12venetoclax 11Mycophenolic Acid 10trametinib 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Multiple Myeloma × Mesna × 1 year × Clear all
NCT03016806 2025-10-10

Umbilical Cord Blood Transplantation From Unrelated Donors

University of Rochester

Recruiting
30 enrolled
Classical hematologyLymphoidMyeloidPlasma cell

Anemia, Aplastic, Immunologic Deficiency Syndromes, Lymphoma, Metabolic Diseases, Multiple Myeloma, Myelodysplastic Syndromes

NCT02356159 2025-09-30

Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed
34 enrolled 18 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡